-
The first China Young Doctors' Minimally Invasive Ablation Professional Skills Competition in South China is about to start
Time of Update: 2022-12-30
Announcement of the event11:10-11:15 Results announced Moderator11:15-11:25 Mentor group11:25-11:30 Competition Summary Professor Xiao YueyongHostInterventional Minimally Invasive Treatment Professional Committee of China Medical Education AssociationMinimally Invasive Tumor Treatment Professional Committee of Chinese Anti-Cancer AssociationAsian Society of CryotherapyAssistedNanjing Yigao Medical Technology Co.
-
Potential first therapy to improve the progression of specific amyotrophic diseases! Phase 3 clinical trials are about to start
Time of Update: 2022-10-19
The press release notes that this may be the first therapy proven to increase glycosylation of αDG protein in LGMD2i patients to reduce muscle wasting and improve disease progression.
-
The 2022 Spondyloarthritis International Symposium is about to open, we look forward to your participation
Time of Update: 2022-08-16
Integrated therapies in spondyloarthritisleave a message here Spondyloarthritis (SpA) is a chronic inflammatory disease affecting the spine and surrounding joints and some internal organs, and is related to congenital genetic genes and acquired environmental factors .
-
For dysmenorrhea conditioning, it is necessary to take Yueyueshu correctly according to different constitutions and time periods
Time of Update: 2022-05-08
One week before menstruation: You can take Yueyue Shutongjingbao Granules, which can warm the meridians and remove blood stasis, regulate qi and relieve pain, used for cold condensing qi stagnation and blood stasis, dysmenorrhea, etc.
-
For this variety of constipation treatment, many pharmaceutical companies have won bids to segment the market
Time of Update: 2022-04-15
On December 28, 2018, Watson Pharmaceuticals announced that the company's polyethylene glycol 4000 powder (specification: 10g) passed the consistency evaluation .
In the second batch of national centralized drug procurement, polyethylene glycol 4000 powder (10g) was won by 4 companies including Watson Pharmaceuticals .
-
Understand in seconds
Time of Update: 2022-03-07
Increased TT4 is more common in hyperthyroidism, TSH-secreting tumors, overuse of thyroid hormones, primary biliary cirrhosis, malignancy, increased thyroid-binding globulin, and increased prealbuminemia.
Commonly seen in primary hypothyroidism, ectopic TSH secretion syndrome, simple goiter, hyperthyroidism, thyroiditis, etc.
Decreased TSH: common in hyperthyroidism, hypothalamic hypothyroidism, hypopituitarism, hypercortisolism, etc.
-
Tasly Xiaoyao tablets were approved by the Dutch Drug Review Board
Time of Update: 2021-10-23
On September 8, Tasly issued an announcement stating that the company received a notice issued by the Dutch Drug Evaluation Committee regarding the approval of the company’s product Xiaoyao Tablets through drug registration (Traditional UseRegistration), which is used to relieve symptoms such as mental stress and fatigue.
-
2021 CSCO Expert Interview｜Professor Cai Qingqing talks about the treatment progress of diffuse large B-cell lymphoma
Time of Update: 2021-10-22
In addition, last year’s ASCO and ESMO meeting reported the results of a phase I/II study of CD19/CD22 dual-targeting CAR-T cells (AUTO3) combined with PD-1 monoclonal antibody for the treatment of R/R DLBCL, using different doses of AUTO3 alone or in combination The ORR of pembrolizumab-treated patients was 68%, the CR rate was 54%, and the duration of complete remission was long.
-
As the innovation of the traditional Chinese medicine industry continues to accelerate, the era of innovative drugs is about to come
Time of Update: 2021-10-20
Regarding the continuous increase in the number of clinical applications and listings of new Chinese medicines, the industry believes that it is the result of China's traditional Chinese medicine industry vigorously promoting innovative development .
-
Shufang Medicine assists Xiangya Second Hospital in launching the first 5D smart diagnosis and treatment center for pulmonary hypertension in China
Time of Update: 2021-10-11
The pictures are: Zhang Chao, founder and CEO of Left Hand Doctor, Li Jiang, Director of Pulmonary and Vascular Disease Subspecialty, Department of Cardiology, Second Xiangya Hospital of Central South University, Yan Zhiyu, Chairman of Shufang Medicine, Xu Qing, Head of Innovative Business Development, Li Dongxue, Product Manager, and Xiangya, Central South University Luo Jun, Attending Physician, Department of Cardiology, Ya Second HospitalAI empowers a new model of doctor-patient connectionPulmonary hypertension is a rare and fatal cardiopulmonary vascular disease.
-
The potential of PD-1/PD-L1 neoadjuvant therapy is gradually showing. Who will become the first "dark horse" in China
Time of Update: 2021-05-08
For bladder cancer, a single-arm, phase II, open study (PURE-01 trial) of pembrolizumab showed that pembrolizumab may be a PD-L1 positive or high TMB muscular infiltrating bladder An effective program for neoadjuvant therapy before surgery for cancer patients.
-
Clinical essentials | Shock wave lithotripsy of upper ureteral calculi
Time of Update: 2021-03-27
Figure 1 The target setting of shock wave focus when SWL is used to treat incarcerated ureteral stones abroad, but the author holds a different view: the upper ureter swings up and down due to the influence of respiration.
-
The new coronavirus allows healthy people to develop diabetes
Time of Update: 2021-03-01
At the same time, patients with neo-coronary pneumonia combined with diabetes are more likely to have higher blood sugar, high blood sugar fluctuations, while the elderly have a high prevalence of type 2 diabetes, cardiovascular disease and other complications, which is also one of the reasons for the higher mortality rate of elderly diabetics infected with the new coronavirus.
-
Dig Dis Sci: Vitamin D deficiency leads to the activation of the colon's local renin-angionein system and exacerbates colon inflammation
Time of Update: 2021-01-22
, the study aims to explore whether vitamin D inhibits local colon RAS activation to reduce inflammation of the colon mucous membranes in mouse models of colitis.
this study confirms that vitamin D deficiency can lead to excessive activeness of local RAS in the colon and promote colon inflammation.
-
NICE supports Calquence (acalabrutinib) in the treatment of chronic lymphocytic leukemia
Time of Update: 2020-12-11
The National Institutes of Health and Clinical Optimization (NICE) has published guidelines in support of AstraZenecom's Calquence as a treatment for chronic lymphocytic leukemia (CLL).
